文献速递糖尿病

胰腺功能不全的囊性纤维化患者口服葡萄糖耐量试验后低血糖与胰岛功能障碍

Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

在胰腺功能不全的囊性纤维化(PI-CF)青少年和年轻成人中开展180分钟口服葡萄糖耐量试验(OGTT)并与历史健康对照组比较,低血糖定义为血糖<65 mg/dL。CF组低血糖发生率65%(15/23),对照组55%(8/15)。CF低血糖者1小时血糖更高、最低血糖更低,早期胰岛素分泌受损、晚期胰岛素暴露更高,胰高血糖素和游离脂肪酸升高幅度更小。

要点

  • PI-CF患者OGTT相关低血糖发生率为65%(15/23)。
  • CF低血糖者1小时血糖197±49 vs 对照139±53 mg/dL(P=0.05),最低血糖48±7 vs 59±4 mg/dL(P<0.01)。
  • CF低血糖者早期胰岛素、C肽和胰岛素分泌率曲线下面积更低,晚期更高(P<0.05)。

核心结论

  • PI-CF中OGTT相关低血糖与1小时血糖升高、早期胰岛素分泌受损、晚期胰岛素暴露更高以及胰高血糖素和游离脂肪酸升高幅度更小相关。
  • 这些数据提示CF中的低血糖是胰岛功能障碍的表现,包括反向调节反应受损。

研究设计与样本

  • 在胰腺功能不全的囊性纤维化(PI-CF)青少年和年轻成人中开展180分钟OGTT并频繁采血,与历史健康对照组比较。
  • 低血糖定义为血浆葡萄糖<65 mg/dL。
  • CF组23例中15例(65%)发生低血糖,年龄24.8(14.6-30.6)岁,43%女性;对照组15例中8例(55%)发生低血糖,年龄26(21-38)岁,33%女性。

主要发现

  • CF低血糖组与对照低血糖组相比,1小时血糖更高(197±49 vs 139±53 mg/dL;P=0.05),最低血糖更低(48±7 vs 59±4 mg/dL;P<0.01)。
  • CF低血糖组胰岛素、C肽和胰岛素分泌率0-30分钟曲线下面积更低,而胰岛素、C肽和曲线下面积120-180分钟更高(P<0.05)。
  • CF低血糖组Δ胰高血糖素120-180分钟和Δ游离脂肪酸120-180分钟低于对照低血糖组(P<0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Oral glucose tolerance test (OGTT)-related hypoglycemia is common in pancreatic-insufficient cystic fibrosis (PI-CF), but its mechanistic underpinnings are yet to be established. OBJECTIVE: To delineate the mechanism(s) underlying OGTT-related hypoglycemia. DESIGN AND SETTING: We performed 180-minute OGTTs with frequent blood sampling in adolescents and young adults with PI-CF and compared results with those from a historical healthy control group. Hypoglycemia (Hypo[+]) was defined as plasma glucose <65 mg/dL. We hypothesized that CF-Hypo[+] would demonstrate impaired early phase insulin secretion and persistent late insulin effect compared with control-Hypo[+], and explored the contextual counterregulatory response. MAIN OUTCOME MEASURE: OGTT 1-hour and nadir glucose, insulin, C-peptide, and insulin secretory rate (ISR) incremental areas under the curve (AUC) between 0 and 30 minutes (early) and between 120 and 180 minutes (late), and Δglucagon120-180min and Δfree fatty acids (FFAs)120-180min were compared between individuals with CF and control participants with Hypo[+]. RESULTS: Hypoglycemia occurred in 15/23 (65%) patients with CF (43% female, aged 24.8 [14.6-30.6] years) and 8/15 (55%) control participants (33% female, aged 26 [21-38] years). The CF-Hypo[+] group versus the control-Hypo[+] group had higher 1-hour glucose (197 ± 49 vs 139 ± 53 mg/dL; P = 0.05) and lower nadir glucose levels (48 ± 7 vs 59 ± 4 mg/dL; P < 0.01), while insulin, C-peptide, and ISR-AUC0-30 min results were lower and insulin and C-peptide, and AUC120-180min results were higher (P < 0.05). Individuals with CF-Hypo[+] had lower Δglucagon120-180min and ΔFFA120-180min compared with the control-Hypo[+] group (P < 0.01). CONCLUSIONS: OGTT-related hypoglycemia in PI-CF is associated with elevated 1-hour glucose, impaired early phase insulin secretion, higher late insulin exposure, and less increase in glucagon and FFAs. These data suggest that hypoglycemia in CF is a manifestation of islet dysfunction including an impaired counterregulatory response.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kilberg MJ, Harris C, Sheikh S, et al. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis. J Clin Endocrinol Metab. 2020. PMID: 32668452. doi:10.1210/clinem/dgaa448

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。